LEXICON PHARMACEUTICALS, INC.

Profile

Company Names

LEXICON PHARMACEUTICALS, INC.
LEXICON PHARMACEUTICALS, INC./DE

Addresses

2445 TECHNOLOGY FOREST BLVD., 11TH FLOOR, THE WOODLANDS, TX 77381

8800 TECHNOLOGY FOREST PLACE, THE WOODLANDS, TX 77381

Phone Numbers

281-863-3000
2818633000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$445,979,402.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2026-02-02 
$55,668,255.00 
$59,150,000.00 
$3,481,745.00 
Equity 
7
2023-06-05 
$72,215,130.00 
$72,215,130.00 
$0.00 
Equity 
6
2022-08-01 
$42,891,000.00 
$49,324,650.00 
$6,433,650.00 
Equity 
5
2017-03-21 
$10,506,500.00 
$10,506,500.00 
$0.00 
Equity 
4
2014-12-04 
$4,662,780.00 
$4,662,780.00 
$0.00 
Equity 
3
2014-11-26 
$150,000,000.00 
$150,000,000.00 
$0.00 
Equity 
2
2012-07-30 
$35,000,000.00 
$35,000,000.00 
$0.00 
Equity 
1
2010-03-19 
$75,035,737.00 
$75,035,737.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KRISTEN 
L. 
ALEXANDER 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC.
PHILIPPE 
J 
AMOUYAL 
DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE
PHILIPPE 
J. 
AMOUYAL 
DIRECTOR
ABOUND SOLAR, INC.   |  LEXICON PHARMACEUTICALS, INC./DE   |  LEXICON PHARMACEUTICALS, INC.
PHILLIPE 
J. 
AMOUYAL 
DIRECTOR
LEXICON PHARMACEUTICALS, INC.
SAMUEL 
 
BARKER 
DIRECTOR
LEXICON PHARMACEUTICALS, INC.   |  CYCLACEL PHARMACEUTICALS, INC.
SAMUEL 
L 
BARKER 
DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE
SAMUEL 
L. 
BARKER 
DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE   |  LEXICON PHARMACEUTICALS, INC.   |  CYCLACEL PHARMACEUTICALS, INC.
PHILIP 
M 
BROWN 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC./DE
IVAN 
H. 
CHEUNG 
DIRECTOR
LEXICON PHARMACEUTICALS, INC.
LONNEL 
 
COATS 
EXECUTIVE OFFICER, DIRECTOR
LEXICON PHARMACEUTICALS, INC.   |  ORION BIOTECHNOLOGY CANADA LTD.
SCOTT 
 
COIANTE 
EXECUTIVE OFFICER
AGILE THERAPEUTICS INC   |  LEXICON PHARMACEUTICALS, INC.
BRIAN 
T. 
CRUM 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC.
RAYMOND 
 
DEBBANE 
DIRECTOR
BLUE BUFFALO CO LTD   |  LEXICON PHARMACEUTICALS, INC./DE   |  CERES, INC.   |  LEXICON PHARMACEUTICALS, INC.   |  WEIGHT WATCHERS INTERNATIONAL INC   |  WW INTERNATIONAL, INC.   |  AVICENNA LIFE SCI US FUND LP
LISA 
 
DEFRANCESCO 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC.
MIKE 
 
EXTON 
EXECUTIVE OFFICER, DIRECTOR
LEXICON PHARMACEUTICALS, INC.
SUMA 
 
GOPINATHAN 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC.
CRAIG 
B. 
GRANOWITZ 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC.
KENNETH 
B. 
KASSLER-TAUB 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC.
PABLO 
 
LAPUERTA 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC./DE   |  LEXICON PHARMACEUTICALS, INC.
ROBERT 
J 
LEFKOWITZ 
DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE
ROBERT 
J. 
LEFKOWITZ 
DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE   |  LEXICON PHARMACEUTICALS, INC.
ALAN 
J 
MAIN 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC./DE
ALAN 
J. 
MAIN 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC./DE   |  LEXICON PHARMACEUTICALS, INC.
RACHEL 
 
MARTENS 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC.
WENDY 
E. 
MCDERMOTT 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC.
ALAN 
S 
NIES 
DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE
ALAN 
S. 
NIES 
DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE   |  LEXICON PHARMACEUTICALS, INC.
JOHN 
 
NORTHCOTT 
EXECUTIVE OFFICER
AVIATION FACILITIES CO INC   |  LEXICON PHARMACEUTICALS, INC.   |  JACKSON PARENT, LP
FRANK 
P 
PALANTONI 
DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE
FRANK 
P. 
PALANTONI 
DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE   |  LEXICON PHARMACEUTICALS, INC.
ARTHUR 
T 
SANDS 
EXECUTIVE OFFICER, DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE
ARTHUR 
T. 
SANDS 
EXECUTIVE OFFICER, DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE   |  NURIX, INC.
ALEXANDER 
 
SANTINI 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC.
KIERNAN 
A. 
SETH 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC.
CHRISTOPHER 
 
SOBECKI 
DIRECTOR
EDUVENTURES, INC.   |  WEIGHT WATCHERS INTERNATIONAL INC   |  ASHLEY STEWART HOLDINGS, INC.   |  THRIVE MARKET, INC.   |  MEOW WOLF, INC.   |  WW INTERNATIONAL, INC.   |  LEXICON PHARMACEUTICALS, INC.
CHRISTOPHER 
J 
SOBECKI 
DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE
CHRISTOPHER 
J. 
SOBECKI 
DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE   |  LEXICON PHARMACEUTICALS, INC.
DIANE 
E. 
SULLIVAN 
DIRECTOR
LEXICON PHARMACEUTICALS, INC.
JUDITH 
L 
SWAIN 
DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE
JUDITH 
L. 
SWAIN 
DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE   |  LEXICON PHARMACEUTICALS, INC.
JAMES 
F 
TESSMER 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC./DE
JAMES 
F. 
TESSMER 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC./DE   |  LEXICON PHARMACEUTICALS, INC.
STEVEN 
A 
TRAGASH 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC./DE
PRAVEEN 
 
TYLE 
EXECUTIVE OFFICER
EYEGATE PHARMACEUTICALS INC   |  LEXICON PHARMACEUTICALS, INC.   |  MAXWELL BIOSCIENCES, INC.   |  KIORA PHARMACEUTICALS INC   |  SKYE BIOSCIENCE, INC.   |  GILA THERAPEUTICS, INC.   |  ORION BIOTECHNOLOGY CANADA LTD.
JEFFREY 
L 
WADE 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC./DE
JEFFREY 
L. 
WADE 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC./DE   |  LEXICON PHARMACEUTICALS, INC.
BRIAN 
P 
ZAMBROWICZ 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC./DE
BRIAN 
P. 
ZAMBROWICZ 
EXECUTIVE OFFICER
LEXICON PHARMACEUTICALS, INC./DE   |  LEXICON PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-02-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-02-02 
2023-06-20
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-06-05 
2022-08-03
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-08-01 
2017-03-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-03-21 
2014-12-12
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2014-12-04 
2014-12-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2014-11-26 
2012-08-07
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2012-07-30 
2010-03-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2010-03-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#